Immunotherapy for head and neck cancers: an update and future perspectives

Immunotherapy. 2019 May;11(7):561-564. doi: 10.2217/imt-2019-0022.
No abstract available

Keywords: HNSCC; PD-L1; PD1; artificial intelligence; biomarkers.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Immunological / therapeutic use*
  • B7-H1 Antigen / antagonists & inhibitors
  • B7-H1 Antigen / metabolism*
  • CD8-Positive T-Lymphocytes / immunology*
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / therapy*
  • Clinical Trials as Topic
  • Head and Neck Neoplasms / immunology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Immunotherapy / trends*
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation
  • NK Cell Lectin-Like Receptor Subfamily C / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / metabolism*

Substances

  • Antineoplastic Agents, Immunological
  • B7-H1 Antigen
  • CD274 protein, human
  • KLRC1 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor